16th Clinical Trials in Canada Summit

$499.00

SKU: PHP16079 Category:

Description

Report Code: PHP16079 | 16th Clinical Trials in Canada Summit | The Old Mill | Toronto

Article 1. Keeping Investigators Interested 

John Akitt
President & Co-Founder
Trial Management Group Inc. (TMG)

Article 2. Keeping Investigators Interested 

Tanya Bridges
Manager, Research Operations
LMC – Manna Research 

Article 3. Clinical Trials 2.0 

Zaynat Khayat, PhD
Senior Advisor of Health System Innovation, MaRS Discovery District
Director, MaRS EXCITE 

Article 4. Best Practices – The Model Clinical Trial Agreement 

Elena Aminkova
Interim Director of Project Facilitation
Canadian Clinical Trials Coordinating Centre (CCTCC)

Article 5. Best Practices – The Model Clinical Trial Agreement 

Cheryl Litchfield
Manager, Grants and Contracts
Lawson Health Research Institute 

Article 6. TransCelerate Overview

Tozheg Roshankar
Country Lead, TransCelerate BioPharma Inc
Regional Research Manager, Eli Lilly Canada Inc. 

Article 7. Clinical Research, Healthcare and Drug Development: Surviving the End of the World as We Know It 

Greg Koski, PhD, MD
President and CEO
Alliance for Clinical Research Excellence and Safety (ACRES) 

Article 8. Is Big Data Just a Pipe Dream? Realizing the Real Power 

Al Pacino
President & Co-Founder
HealthCarePoint 

Article 9. More than Just a Data Point – Engaging Patients in Clinical Trials 

Eddy Nason
Assistant Director
Ontario Strategy for Patient Oriented Research (SPOR)
SUPPORT Unit 

Article 10. Patient Protection, Engagement & Informed Consent: Putting “Informed” back into “Informed Consent” 

Ron Heslegrave , PhD
Corporate Chief of Research
William Osler Health System 

Article 11. Presentation and Discussion of Bial-Biotrial Events in France 

Dr. Richard Larouche
VP Medical Affairs
inVentiv Health Clinical

Article 12. Wearables for Clinical Trials: Promises and Challenges

Dr. Hamid Najafi
CEO
Sensoplex, Inc. 

Article 13. The Essential Need to Embed Privacy, by Design into Clinical Trials 

Ann Cavoukian, PhD
Executive Director, Privacy and Big Data Institute
Ryerson University 

Article 14. Getting the World Excited about Doing Clinical Trials in Canada 

Elena Aminkova
Interim Director of Project Facilitation
Canadian Clinical Trials Coordinating Centre (CCTCC) 

Article 15. Clinical Trials: “The Canadian Advantage”. Can We do More? 

Dr. Richard Larouche
VP Medical Affairs
inVentiv Health Clinical 

Article 16. Getting the World Excited About Doing Clinical Trials in Canada 

Dr. Graham Wood
Executive Vice President, Phase I Clinical Development
Altasciences | Algorithme Pharma